- $343.01bn
- $400.53bn
- $54.32bn
- 80
- 30
- 93
- 75
REG-BARCLAYS PLC Form 8.3 - ABBVIE INC - Amendment
AnnouncementREG-TIAA-CREF Form 8.3 - AbbVie Inc.
AnnouncementREG-BARCLAYS PLC Form 8.3 - Abbvie Plc - Amendment
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(a) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
AnnouncementREG-BARCLAYS PLC Form 8.3 - ABBVIE INC
AnnouncementREG-TIAA-CREF Form 8.3 - AbbVie Inc.
AnnouncementREG - T.Rowe Price Assoc - Form 8.3 - [AbbVie Inc]
AnnouncementREG-BARCLAYS PLC Form 8.3 - ABBVIE PLC
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (a) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
AnnouncementREG - T.Rowe Price Assoc - Form 8.3 - [AbbVie Inc]
AnnouncementREG-BARCLAYS PLC FORM 8.3 - ABBVIE PLC - AMENDMENT
AnnouncementREG-TIAA-CREF Form 8.3 - AbbVie Inc.
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (a) - AbbVie Inc
Announcement